Successful Use of Omalizumab in an Inadequately Controlled Type 2 Diabetic Patient With Severe Insulin Allergy

por Cavelti-Weder, Claudia, Muggli, Bettina, Keller, Cornelia, Babians-Brunner, Andrea, Biason-Lauber, Anna, Donath, Marc Y., Schmid-Grendelmeier, Peter
Publicado 2012

Inhibition of IL-1β Improves Fatigue in Type 2 Diabetes

por Cavelti-Weder, Claudia, Furrer, Romana, Keller, Cornelia, Babians-Brunner, Andrea, Solinger, Alan M., Gast, H., Fontana, A., Donath, Marc Y., Penner, Iris K.
Publicado 2011

Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes

por Cavelti-Weder, Claudia, Babians-Brunner, Andrea, Keller, Cornelia, Stahel, Marc A., Kurz-Levin, Malaika, Zayed, Hany, Solinger, Alan M., Mandrup-Poulsen, Thomas, Dinarello, Charles A., Donath, Marc Y.
Publicado 2012